Constellation Pharmaceuticals, Inc.
CNST
CNST was delisted on the 14th of July, 2021.
100 hedge funds and large institutions have $1.8B invested in Constellation Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 3 closing their positions.
1,733% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 3
1,292% more capital invested
Capital invested by funds: $129M → $1.8B (+$1.67B)
300% more funds holding in top 10
Funds holding in top 10: 3 → 12 (+9)
229% more call options, than puts
Call options by funds: $2.65M | Put options by funds: $807K
117% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 12
108% more funds holding
Funds holding: 48 → 100 (+52)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$105M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$81.5M |
| 3 |
VMI
VHCP Management III
New York
|
+$70.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$56.2M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$32.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$15.9M |
| 2 |
CC
Casdin Capital
New York
|
-$8.99M |
| 3 |
O
OrbiMed
New York
|
-$5.4M |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$1.59M |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$1.44M |
CNST Hedge Fund Activity: Q4 2019 in Review
100 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q4 2019, worth a combined $1.8B — up 1,292% from $129M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new CNST positions and 3 closed out — a net gain of 52 holders — while 26 added to existing stakes and 12 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $105M. The largest seller was Regents of the University of California, cutting an estimated $15.9M.
- 100 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q4 2019, up from 48 in Q3 2019.
- Funds reported $1.8B of Constellation Pharmaceuticals, Inc. stock for Q4 2019, up 1,292% quarter-over-quarter.
- 55 funds opened new Constellation Pharmaceuticals, Inc. positions in Q4 2019 and 3 closed out, a net change of +52 holders.
- The largest Constellation Pharmaceuticals, Inc. buyer in Q4 2019 was Avoro Capital Advisors, an estimated $105M added.
- The largest Constellation Pharmaceuticals, Inc. seller in Q4 2019 was Regents of the University of California, an estimated $15.9M sold.
Based on aggregated 13F filings for Q4 2019.